We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Point-Of-Care Chemistry Test (POCT) Effect on the Emergency Department (ED)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00942955
First Posted: July 21, 2009
Last Update Posted: July 21, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Hospital
  Purpose
The hypothesis of this study is that POCT will shorten ED turn-around-time (TAT) such as blood drawing TAT, lab TAT, and decision TAT.

Condition
Emergency Department Length of Stay Turnaround-time

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Randomized Controlled Multi-center Trial of a Point-Of-Care Chemistry Test for Reduction of Turnaround and Clinical Decision Time in the Emergency Department

Further study details as provided by Seoul National University Hospital:

Study Start Date: January 2009
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
CLT
The patients whose blood are analyzed by conventional central laboratory.
POCT
the patients group whose lab analyze by POCT device.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
This study was performed in five EDs. Three were urban EDs with 30,000 to 45,000 annual visits, and two were suburban EDs with 15,000 to 25,000 annual visits. Each hospital has its own central laboratory which can test the same emergency chemistry tests, including liver panel (alkaline phosphatase, protein, albumin, total bilirubin, direct bilirubin, GOT, and GPT), renal panel (BUN, creatinine, calcium, and phosphorus), pancreas enzymes (amylase, lipase), electrolytes (sodium, potassium, chloride, total CO2), lipid panel (total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol), and blood gases (pH, pO2, pCO2, and bicarbonate).
Criteria

Inclusion Criteria:

  • Patients older than 15 years
  • clinically required to have chemistry lab tests
  • agreement

Exclusion Criteria:

  • no agreement
  • ESI level 1
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Shin Sang Do/Assistant professor, Seoul National University Hospital Department of Emergency medicine
ClinicalTrials.gov Identifier: NCT00942955     History of Changes
Other Study ID Numbers: SNUEMS200801
First Submitted: July 20, 2009
First Posted: July 21, 2009
Last Update Posted: July 21, 2009
Last Verified: July 2009

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes